FDA Investigates Merck Drug-Suicide Link

WASHINGTON (AP) — The Food and Drug Administration said Thursday it is investigating a possible link between Merck’s best-selling Singulair and suicide.

FDA said it is reviewing a handful of reports involving mood changes, suicidal behavior and suicide in patients who have taken the popular allergy and asthma drug.

For more information, follow the link below.

Read More About FDA Investigates Merck Drug-Suicide Link…